" class="no-js "lang="en-US"> 3Z - Medtech Alert
Thursday, March 30, 2023
3Z | Pharmtech Focus


About 3Z

3Z incorporates the latest advances in disease modeling and behavioral genetics to discover novel drug candidates for CNS disorders.

Related Story

3Z Closes $2 Million Funding for Preclinical Development of Novel ADHD and Insomnia Therapeutics Identified by 3Z´s Zebrafish Drug Discovery Platform

June 21 2022

3Z, a Reykjavik based drug discovery company is pleased to announce the closure of a $2 million funding round […]